Home > Boards > US OTC > Cannabis >

Cannabix Technologies Inc. (BLOZF)

Add BLOZF Price Alert      Hide Sticky   Hide Intro
Moderator: shell3
Search This Board: 
Last Post: 9/6/2020 6:10:11 PM - Followers: 309 - Board type: Free - Posts Today: 0

Cannabix Technologies Inc.

(formerly West Point Resources Inc.)

Frankfurt: 8CT:FRA)

And is a Vancouver, B.C. based  company

Cannabix Technologies Inc. has
the exclusive North American license for
the Cannabix Marijuana Breathalyzer
from Cannabix Breathalyzer Inc.

Cannabix Technologies Inc. has
Worldwide Rights to
Partial ovoidal FAIMS electrode"
Patent 8,237,118
from the University of Florida



Rights for 10 Years after 1st Product sold

What is FAIMS-MS?

It Blocks Out Unwanted Molecules
 Letting only THC Molecules Threw the Electrode
40 Minute Video with Dr Yost


Cannabix Technologies' Inc. common shares trade on
the Canadian Securities Exchange
and US OTC Pinksheets and European Frankfurt Exchange.

US Patent Application

Canada Patent Application

Cannabix Technologies Inc. is the developer of the patent pending Cannabix Marijuana Breathalyzer for law enforcement and the workplace. The Cannabix Marijuana Breathalyzer drug-impairment recognition system is based on breath testing technology that has been developed to test individuals for recent consumption of the THC component of marijuana.  Cannabix is advancing its products to enable law enforcement personnel to use this technology to enhance detection of marijuana impaired driving offences on North American roads at a time when marijuana is becoming legal in many jurisdictions.  Cannabix is working to develop a drug-testing device that will detect Tetrahydrocannabinol (THC- the psychoactive component of marijuana that causes intoxication) using breath samples. The device would be used to provide detection of THC at the roadside to identify drivers intoxicated by the use of marijuana. The device will also be useful for other practical applications such as testing employees in the workplace where intoxication by THC can be hazardous.
The device is currently in BETA 1.0 development and the Company is rapidly developing this technology for BETA 2.0 for Third Party Testing 


CSE:BLO          Pinksheets: BLOZF  Frankfurt: 8CT:FRA

Common Shares
Issued and Outstanding 
 (as of May 5th, 2018)
Warrants Issued but not Exercised  
Options Issued but not Exercised  7,076,000
IF a Patent is Issued another 5M Shares

Fully Diluted w/Warrants, w/Options  and w/Patent 5M Shares


Cannabix Corporate Video

Kal Malhi, President and Director
Kal Malhi, President, Director Mr. Malhi is a Vancouver based entrepreneur and the founder of Cannabix Breathalyzer Inc.  Mr. Malhi is a retired member of the Royal Canadian Mounted Police and is also President of BullRun Group, a private investment company specializing in early stage business development.  Mr Malhi brings a wealth of business and law enforcement experience to the management team and is cognizant of the issues of protecting individuals’ rights to privacy while maximizing public safety through law enforcement initiatives.

Dr. Raj Attariwala, MD, PhD.,  Lead Engineer
Dr. Attariwala is a Vancouver based dual board certified Radiologist and Nuclear Medicine physician certified in both Canada and the United States. He received his formal medical training at University of British Columbia with periods of specialized medical training at Memorial Sloan Kettering Cancer Centre (New York), UCLA and USC. He holds a doctorate in Biomedical Engineering from Northwestern University (Evanston, IL).  Dr.  Attariwala is a practicing physician in British Columbia and is the owner of AIM medical imaging in Vancouver.  He has pioneered advances in the field of whole body medical imaging thru his work and authored numerous publications and presented at international medical conferences on whole body imaging and cancer detection. Dr Attariwala has worked closely with the breath testing technology developed by the Karolinska Institute and Dr Olof Beck and utilized his educational training and background in Biomedical Engineering to formulate product design and patent applications for Cannabix Breathalyzer products.  Dr.  Attariwala also has several other medical device patents under developments in the field of Nuclear Medicine.

Dr. Bruce Goldberger, PhD,  Senior Advisor
Dr. Goldberger is a professor, and the director of toxicology for the Department of Pathology, Immunology and Laboratory Medicine in the College of Medicine at the University of Florida.  Dr. Goldberger is the editor-in-chief of the Journal of Analytical Toxicology; the president of the American Board of Forensic.

Richard A. Yost Ph.D., Scientific Advisor

Dr. Yost, Col. Allen R. & Margaret G. Crow Professor and Head of Analytical Chemistry at the University of Florida received his B.S. degree in Chemistry from the University of Arizona in 1974. In 1975 he pursued an NSF graduate fellowship at Michigan State University focusing on electronics and computerized instrumentation. He received his Ph.D. in 1979 and assumed the position of Assistant Professor at the University of Florida and went on to become head of the Analytical Chemistry Division.

Jared Boock Ph.D, Principal investigator
Worked on a high-field asymmetric waveform ion mobility spectrometry (FAIMS) - based
method of detection for transition metals. Conducted characterization of the types of ions that form
during the electrospray ionization (ESI) process for over 25 metal salts. Invented an atmospheric
pressure ion guide (patent pending). Taught four semesters of analytical chemistry laboratory; recipient of the Department of Chemistry Teaching Award for 2015.

Rocco Iannapollo, Advisor
Mr. Iannapollo is an expert on substance abuse programs with more than 20 years of experience in the oil and gas industry, working for fortune 50 companies. Rocco has extensive experience with supplier, employer, and DOT compliance policies and strategies. He also brings deep business acumen regarding operations and supply chain best practices. Mr. Iannapollo is a member of the Substance Abuse Program Administrator’s Association (SAPAA), the Drug and Alcohol Testing Industry Association (DATIA), as well as a speaker and regular contributor to the International Forum for Drug and Alcohol Testing (IFDAT).

Rav Mlait, MBA – CEO, Director
.Mr. Mlait has extensive experience in managing and raising capital for public and private companies. Mr. Mlait holds an MBA from Royal Roads University in British Columbia with a specialization in Executive Management and his BA (Economics) from Simon Fraser University and has worked with public companies listed on the TSX and TSX Venture exchange. Mr. Mlait was VP of Corporate development for knowledge-management and CRM software developer, Knexa Solutions Ltd., and financial web portal, Stockhouse Media Corporation.

Bryan Loree BA, CMA –CFO, Director
Mr. Loree has held various senior accounting roles for public and private companies in various industries including, renewable energy, exploration, and construction. During this time he has also performed capital raising activities for both private and public companies, primarily in the exploration and renewable energy sectors. Prior to entering the accounting field, Mr. Loree spent three years as an investor relations manager for public exploration companies and two years in the banking industry. Mr. Loree holds a Certified Management Accountant designation, a Financial Management Diploma from the British Columbia Institute of Technology, and a BA from Simon Fraser University.

Thomas Clarke, M,Sc, Director
Mr. Clarke served as a geologist for TSX Venture listed, BonTerra Resources from May 2010 to October, 2012. During his tenure, BonTerra defined an initial NI 43-101 compliant resource under his leadership. Thomas is a geologist holding a BSc. (Honours) and MSc in Geology from the University of the Witwatersrand as well as a BSc in Geography from the University of Lethbridge. 

Andrew Davies,  Advisor
Mr. Davies is a cannabinoid expert who has over 25 years of experience in the pharmaceutical industry and was instrumental in securing the first US IND for synthetic Cannabidiol (CBD) at Yale University. Andrew is a Chartered Mechanical Engineer and holds a BEng from the University of Liverpool and an International Executive MBA from the University of Middlesex Business School, London. Andrew is the CEO of STI Pharmaceuticals Ltd., a leading cannabinoid research company based in London, England. He is also a sought after speaker at cannabinoid conferences globally.

Dr. (h.c.) Marilyn Huestis, PhD, Scientific Advisor
Dr. Huestis is one of the world’s foremost experts on the effects of marijuana use on driving impairment. Dr. Huestis is a sought after international speaker, scholar and scientist. Dr. Huestis was a tenured Senior Investigator and Chief of Chemistry and Drug Metabolism at National Institute for Drug Abuse (NIDA’s) Intramural Research Program (IRP) in Baltimore, Maryland and a Professor at the University of Maryland School of Medicine (retired in 2016).  Dr. Huestis received her Bachelor’s degree (cum laude) in Biochemistry from Mount Holyoke College, a Master's in Clinical Chemistry with honors from the University of New Mexico, and a Ph.D. in Toxicology with honors from the University of Maryland School of Medicine. 

Current Price
Bid Ask Day's Range
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BLOZF News: Cannabix Technologies Provides Update on THC Breath Analyzer Development and Testing 08/13/2020 08:45:00 AM
BLOZF News: Cannabix Technologies Files Patent for Detection of Molecules in Breath using High-field asymmetric waveform ion mobility spe... 07/06/2020 11:03:00 AM
BLOZF News: Cannabix Technologies Develops Version 2.0 of THC Breath Analyzer 05/11/2020 08:45:00 AM
#26711   I was surfin' around some of my dd geodcan 09/06/20 06:10:11 PM
#26710   They cancelled the expensive Options so they could shell3 09/02/20 10:32:00 AM
#26709   So... They forgot to cash them in ? Carthnel 09/02/20 10:26:52 AM
#26708   Subsequent Event — MD&A & Financials were Filed shell3 08/29/20 12:40:59 AM
#26707   It's a snooze fest in here. Harryist1 08/26/20 09:52:09 PM
#26706   $BLOZF should get a MD&A anyday now shell3 08/20/20 08:38:01 PM
#26705   Whooooaaa Big Fella. I still believe BLOZF! Nelson2 08/20/20 06:53:58 PM
#26704   They posted another update regarding and update to Harryist1 08/17/20 08:04:45 PM
#26703   Doesn't appear to be any scientists, researchers, etc... HealthMngr 08/17/20 10:19:08 AM
#26702   Canadian nr said that they are human testing geodcan 08/14/20 05:43:17 PM
#26701   Divisional patent application found today. Check out entries HealthMngr 08/14/20 02:33:53 PM
#26700   Been a few months since reading "Topical review HealthMngr 08/13/20 11:23:37 PM
#26699   HELLO INTHEKNOW1 08/13/20 03:37:15 PM
#26698   Old conversation/ probable cause.. rocks the answer. Plus Carthnel 08/13/20 01:47:49 PM
#26697   Unless the device is going to show the D Mooo 08/13/20 01:31:07 PM
#26696   Dang 334k that’s like .. 2 new people. Carthnel 08/13/20 12:08:35 PM
#26695   ORIGINAL: Cannabix Technologies Provides Update on THC Breath drt1111 08/13/20 09:05:02 AM
#26694   Any revenues, ever? TonyJoe1957 08/13/20 08:50:37 AM
#26693   Yo AMG... Where’d you go? GOLD DIGGAA 08/11/20 07:29:05 AM
#26692   What’s good boys? GOLD DIGGAA 08/11/20 07:24:45 AM
#26691   Outstanding: 105,124,104 shares for August 5, 2020 shell3 08/05/20 08:10:40 AM
#26690   except AGN with their covid repurposed drugs that geodcan 07/17/20 05:39:41 PM
#26689   Still holding some of its latest pop. geodcan 07/17/20 05:38:13 PM
#26688   Field Sobriety tests by an Officer at initial tcm55 07/16/20 02:09:54 PM
#26687   Anyone know a police officer out there? I Lakehaus 07/16/20 01:05:19 PM
#26686   Geo was just posting info he wanted to tcm55 07/16/20 12:34:29 PM
#26685   I point out one scam, and you reply AMG 07/11/20 02:46:26 PM
#26684   It wasn't a pump. Just a symbol geodcan 07/11/20 01:43:21 PM
#26683   Sounds logical geodcan. AMG 07/10/20 05:40:49 PM
#26682   Still in the black with a 2 or geodcan 07/10/20 03:53:20 PM
#26681   Yeah...call it having 20/20 Vision of how the AMG 07/09/20 04:25:38 PM
#26680   Wait for it.... drt1111 07/09/20 03:36:26 PM
#26679   Somebody seems to be able to spike the geodcan 07/09/20 03:20:44 PM
#26677   That was fun and profitable. See you next GOLD DIGGAA 07/08/20 02:58:05 PM
#26676   The 5th report also mentioned newly hired engineers.., Carthnel 07/08/20 10:09:59 AM
#26675   Chart looks like a breakout may be coming...cup drt1111 07/07/20 06:08:00 PM
#26674   Party time ? Tyreek Hill 07/07/20 04:19:55 PM
#26673   Great day for $BLOZF! Congrats to all GVX808 07/07/20 02:32:52 PM
#26672   Wow, somebody found yesterday’s email! Carthnel 07/07/20 01:40:23 PM
#26671   I just about through it out there that geodcan 07/06/20 03:18:41 PM
#26670   News: $BLOZF Cannabix Technologies Files Patent for Detection whytestocks 07/06/20 01:15:24 PM
#26669   Or at least keep a nickel. I’m sure Carthnel 07/06/20 12:54:02 PM
#26668   It sure would be nice to see a Carthnel 07/06/20 11:10:55 AM
#26667   LET $BLOZF RUN !! shell3 07/06/20 10:25:55 AM
#26666   Looking good.... +15% GOLD DIGGAA 07/06/20 09:32:19 AM
#26665   Let’s hope the world remember’s this stock with Carthnel 07/06/20 09:14:23 AM
#26664   WHO’S READY TO PARTY!?!? GOLD DIGGAA 07/06/20 09:01:49 AM
#26663   I am still in as well. Sold off Harryist1 07/03/20 05:48:54 PM
#26662   I've still got black ink on this stock geodcan 07/03/20 03:59:55 PM
#26661   Now that we settled that @ BLOZF AMG 07/02/20 08:30:41 PM
Consent Preferences